Protagonist Therapeutics, Inc. (PTGX) Price Forecast — AI Targets | MarketCI

Protagonist Therapeutics, Inc. (PTGX) Price Forecast — AI Targets | MarketCI | MarketCI

PTGX

Market Closed

Protagonist Therapeutics, Inc.

NASDAQHealthcare Biotechnology

132 employees

CEO: Dinesh V. Patel

Founded: 2016

$136.11

+$0.00(+NaN%)

Market Cap

8.75B

Beta

1.79

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Forecasting Analysis

AI-powered predictions and statistical risk modeling for short-term price movements

AI Insight:

AI short-term forecasts for Protagonist Therapeutics are trending modestly lower, indicating near-term downside risk. Analyst consensus projects more pronounced downside over 12 months, with strong coverage and a tight agreement among analysts. This convergence signals broad market caution regarding the stock’s outlook.

Current Price

N/A

Last closing price

Price Prediction

Machine learning prediction based on historical price patterns

Period:

Analyst Price Target for PTGX

Loading analyst price targets...

Wall Street Forecasts

Revenue Forecast

Past Growth

N/A

Based on Historical CAGR

Forward Growth

N/A

Projected CAGR

Analyst Accuracy

Estimate Accuracy

Revenue Analysis

Comparison of Actual and Estimated Revenues

Loading chart data...

Revenue growth steady at 0.0%.

Operating Profitability Forecast

Past Growth

N/A

EBITDA Historical CAGR

Forward Growth

N/A

EBITDA Projected CAGR

Analyst Accuracy

Estimate Accuracy

EBITDA Analysis

Comparison of Actual and Estimated EBITDA

Loading chart data...

EBITDA maintaining 0.0% trajectory.

Earnings Per Share Forecast

Past Growth

N/A

EPS Historical CAGR

Forward Growth

N/A

EPS Projected CAGR

Analyst Accuracy

Estimate Accuracy

EPS Analysis

Comparison of Actual and Estimated Earnings Per Share

Loading chart data...

EPS growth stable around 0.0%.

Explore PTGX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PTGX in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →